Form D · Other Technology
Geno.Me, Inc.
Milwaukee, WI · CIK 0001895616
Offering snapshot reported May 5, 2025 · SEC filing
- Reported sold
- $200K Offering amount: $650K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 30, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 5, 2025 | Initial | $200,000 | No comparison | 2 | SEC filing |
| Oct 13, 2022 | Initial | $2,200,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-545218
Source: Form D, filed May 5, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Paul Auer | Director |
| Mark Bakken | Director |
| Brittany Gottschalk | Director, Executive |
| Laura Hilty | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
507 S. 2nd Street Suite 130
Milwaukee, WI, 53204
Milwaukee, WI, 53204